Â
Paula Dias Figueiredo Joins KAI Conversations as Board Advisor, Bringing Deep Expertise in MedTech, AI, and Growth Strategy
London, 20th May 2025
KAI Conversations, the leading conversation intelligence platform for the life sciences industry, today announced the appointment of Paula Dias Figueiredo 🔷 as a Board Advisor. With over 20 years of experience advising C-level executives at Forrester and a strong track record in scaling MedTech, AI, and digital health companies, Paula's expertise will be invaluable in guiding KAI Conversations' growth and strategic direction.
Paula brings deep expertise in board-level strategy, market expansion, corporate governance, disruptive technologies, AI-driven transformation, and venture capital. Her focus on positioning high-growth businesses for market leadership aligns perfectly with KAI Conversations' mission to empower life sciences organizations through innovative AI-powered insights.
"We are delighted to welcome Paula to our advisory board," said David Williams, Founder & CEO of KAI Conversations. "Paula's extensive experience in the MedTech and AI sectors, coupled with her proven ability to drive growth, will be a tremendous asset to KAI Conversations as we continue to expand our impact within the life sciences industry."
Paula Dias Figueiredo commented on her appointment, stating, "“Pharma spends over $20 billion a year on sales and MSL engagement—yet over 70% of HCPs say it’s not worth their time. That’s broken. KAI Conversations fixes it.”
“This isn’t an upgrade—it’s a reset in how the industry connects, learns, and delivers value. Leading pharma companies are already seeing results across medical, commercial, global capabilities, and L&D. Their leadership is setting a new standard—one that others are struggling to catch—by challenging conventional thinking and driving meaningful change.
I’m looking forward to working with the visionary KAI Conversations team to scale the business, forge strategic partnerships, and achieve their bold ambitions in a rapidly evolving market. Together, we’ll ensure KAI leads the future of life sciences engagement."
KAI Conversations' platform utilizes advanced AI to analyze and understand conversations between life sciences professionals and HCPs, providing actionable insights that drive more meaningful and effective engagements. Paula's strategic guidance will further accelerate KAI Conversations' growth and solidify its position as the leading platform enabling impactful communication within the life sciences sector.Contact:
David Williams
davidw@kaiconversations.com
www.kaiconversations.ai
